Literature DB >> 24628283

Reversible cerebral vasoconstriction syndrome after blood transfusion.

Yi-Hsuan Dou1, Jong-Ling Fuh, Shih-Pin Chen, Shuu-Jiun Wang.   

Abstract

OBJECTIVES: To report 2 cases of reversible cerebral vasoconstriction syndrome (RCVS) with posterior reversible encephalopathy syndrome (PRES) after blood transfusion for severe anemia.
BACKGROUND: RCVS is presented with recurrent thunderclap headache and reversible constriction of cerebral arteries. PRES is a known complication of RCVS. Blood transfusion for severe anemia could be a cause for PRES in few cases; however, it is seldom mentioned as an etiology for RCVS.
METHODS: We report a case series.
RESULTS: We report 2 women presented with RCVS with PRES after blood transfusion for anemia, and reviewed another 4 similar cases reported in the literature. Our 2 patients were middle-aged women, with severe chronic anemia (average hemoglobin: 1.45 g/dL), and received multiple blood transfusions (average: 3250 mL) over a period of 5-7 days. They developed thunderclap headache and other symptoms about 1 week after the last blood transfusion. Cerebral vasoconstrictions were demonstrated by magnetic resonance angiography and transcranial color-coded sonography. PRES was found in both of them using magnetic resonance imaging, and one of them also had cytotoxic edema on diffusion weighted image.
CONCLUSIONS: RCVS with PRES is one complication of blood transfusion in patients under chronic severe anemia (especially when hemoglobin level increased for more than 5 g/dL), particularly in Asian women with menorrhagia. Blood pressure surge and the occurrence of severe headaches or other neurological symptoms should be aggressively monitored within 10 days after the last blood transfusion.
© 2014 American Headache Society.

Entities:  

Keywords:  blood transfusion; chronic anemia; posterior reversible encephalopathy syndrome; reversible cerebral vasoconstriction syndrome

Mesh:

Year:  2014        PMID: 24628283     DOI: 10.1111/head.12319

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  8 in total

Review 1.  Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-15       Impact factor: 3.825

2.  Reversible Cerebral Vasoconstriction Syndrome and Posterior Reversible Encephalopathy Syndrome Presenting with Deep Intracerebral Hemorrhage in Young Women.

Authors:  Won Jae Lee; Je Young Yeon; Kyung-Il Jo; Jong-Soo Kim; Seung-Chyul Hong
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2015-09-30

3.  Surviving Extreme Anaemia.

Authors:  Joana M Esteves; Joana Fernandes; Pedro Oliveira Monteiro; Mariana Almeida; Luis Nogueira-Silva; Jorge Almeida
Journal:  Eur J Case Rep Intern Med       Date:  2021-03-05

4.  Reversible cerebral vasoconstriction syndrome following red blood cells transfusion: a case series of 7 patients.

Authors:  Hui Liang; Ziqi Xu; Zhijun Zheng; Haiyan Lou; Wei Yue
Journal:  Orphanet J Rare Dis       Date:  2015-04-22       Impact factor: 4.123

Review 5.  Posterior reversible encephalopathy syndrome with extensive cytotoxic edema after blood transfusion: a case report and literature review.

Authors:  Yoshitsugu Nakamura; Masakazu Sugino; Akihiro Tsukahara; Hiroko Nakazawa; Naomune Yamamoto; Shigeki Arawaka
Journal:  BMC Neurol       Date:  2018-11-12       Impact factor: 2.474

6.  Spatial and temporal patterns of nitric oxide diffusion and degradation drive emergent cerebrovascular dynamics.

Authors:  William Davis Haselden; Ravi Teja Kedarasetti; Patrick J Drew
Journal:  PLoS Comput Biol       Date:  2020-07-27       Impact factor: 4.475

7.  Blood-transfusion-related posterior reversible encephalopathy syndrome - A description of a new case and review of the literature.

Authors:  Mukesh Dube; Rashi Rathore
Journal:  Brain Circ       Date:  2020-12-29

8.  Reversible cerebral vasoconstriction syndrome with cardiac involvement during treatment for iron deficiency anemia: caser report.

Authors:  Kenya Oguchi; Kazuhiro Fukushima; Akinori Nakamura; Yo-Ichi Takei
Journal:  BMC Neurol       Date:  2021-12-10       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.